Interesting voting results from #apccc24 consensus panel on whether ePLND should still be done with negative PSMA PET for unfavorable intermediate, high and very high risk #ProstateCancer

Important discussion about pros/cons of changing TNM staging to include MRI findings rather than DRE. Concerns about implications of this for radiation + hormonal therapy #apccc24

Compelling argument by Alberto Briganti on using surgery for management of high-risk #Prostatecancer and how this can actually de-intensify treatment for some patients #apccc24

Using Decipher and artificial intelligence biomarkers to personalize the use and duration of androgen deprivation therapy for high-risk #Prostatecancer -Daniel E Spratt #apccc24

PSMA has 80-90% NPV but poor sensitivity for pelvic lymph nodes - cannot replace staging extended PLND. Plus new data that ePLND reduces distant metastases -Jochen Walz #apccc24

RIP Digital rectal examination? ☠️ Nice summary by Declan Murphy of the limitations of DRE in the primary care setting and for early detection for urologists (in settings where high quality MRI is available) #APCCC24

Nuances and challenges of defining high-risk #prostatecancer by Martin Gleave #apccc24 -recommends stratifying high risk group into tiers based on risk factors

‘It Just Makes Sense to Me’: A qualitative study exploring patient decision-making and experiences with prostate MRI during active surveillance for #ProstateCancer
Cary Gross Stacy Loeb, MD Matt Cooperberg

doi.org/10.1002/bco2.3…

Read about TARGET, a randomized non-inferiority trial to compare pretest genetic education via a webtool for noninferiority to traditional genetic counseling (GC) in patients with #ProstateCancer (PCA). ➡️ brnw.ch/21wJ86I Stacy Loeb, MD Veda Giri #pcsm

Welcome to Lugano🇨🇭for Advanced Prostate Cancer Consensus Conference! Talk about a room with a view! Thanks @SilkeGillessen aurelius omlin for the hospitality! Looking forward to an outstanding program #apccc24

New evidence-based PCF Prostate Cancer Screening Guidelines for Black Men in the U.S. recommend that Black men consider PSA screening between ages 40-45, and screen annually depending on PSA levels and health status. 🧵⬇️

#AUA 24 is less than a month away! 😎 Click here to explore this year's program and more ➡️ bit.ly/3JluLLN

#AUA #Urology #AUA Members Stacy Loeb, MD

Only 4% of cancer survivors adhered to all 4 American Cancer Society guidelines, with the mean number met being 2
The guidelines
1. physical activity
2. body mass index
3. alcohol use
4. fruit & vegetable intake
Much work to be done to improve adherence!

jamanetwork.com/journals/jamao…

🌟 Just 1 Week to Go Until #APCCC24 ! 🌟

🚀 Are you ready for the most anticipated oncology conference of the year? APCCC 2024 kicks off next week, April 25-27, in the stunning city of Lugano🇨🇭!

With our hybrid format, don't miss your chance to be part of this transformative

New interview from Medscape with the brilliant Stacy Loeb, MD

medscape.com/viewarticle/10…

VA faculty Dr. Laura Mihalko moderating a panel on complex prostate cancer cases with Stacy Loeb, MD Kara Watts and Dr. Marklyn Jones.

#RMUS2024 #RMUS24 #prostatecancer #UroSoMe

Nice lecture by Garrett D Pohlman, M.D. on the benefits of podcasting for the busy urologist! Podcasts are increasingly popular- a great way to share information with your own patients as well as others around the world #rmus24

Stacy Loeb, MD giving excellent overview of the 'rosy' benefits and 'dark harms' of social media in prostate cancer

Benefits:
Research
Promoting clinical information
Patient support

Harms:
Accuracy
Readability/understandability
Equity

#RMUS24

In the future #ArtificialInteligence may help us predict the true extent of #prostatecancer which could help with upfront treatment selection or treatment planning -Kara Watts #rmus24

Same day discharge for prostatectomy is safe with no increased complications for the patient or increased workload for the healthcare system Janet Kukreja #rmus24